Work

Macro Solutions to a Micro Problem: Drug-resistant Pneumococcal Pneumonia.

Year: 2025

Type: article

Abstract: threatened to render standard empiric antibiotic therapy ineffective. One of the biggest drivers of pneumococcal drug resistance is antibiotic overuse, among both adults and children. While the introduction of the pneumococcal conjugate vaccine in 2000 dramatically impacted the overall incidence of pneumococcal pneumonia in both children and adults, the levels of antibiotic resistance have remained significant. To reduce the overuse of antibiotics requires multidimensional interventions targeting patients, clinicians, and health systems. Studies have demonstrated improvement in this area, but the quality gap remains high. Future work will focus on organizational strategies and policies that optimize antibiotic use for patients with antibiotic responsive acute illnesses.

Source: PubMed

Author: Joshua P Metlay

Language: English

Topic: Antibiotic Use and Resistance

Subfield: Applied Microbiology and Biotechnology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Veterans Affairs, Massachusetts General Hospital, University of Pennsylvania, National Institutes of Health, Centers for Disease Control and Prevention, University of California, San Francisco

OpenAlex ID: W4413048523

FWCI:

Cites: 1

Cited by:

Related to: 10